Evidence map›Paper›PMID 30190479›Full record

ArticleBlood cancer journal2018

Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.

Julia J Unterluggauer, Katharina Prochazka, Peter V Tomazic, Heinrich J Huber, Rita Seeboeck, Karoline Fechter, Elisabeth Steinbauer, Verena Gruber, Julia Feichtinger, Martin Pichler and 8 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Julia J UnterluggauerDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Katharina ProchazkaDivision of Hematology, Medical University of Graz, Graz, Austria.
Peter V TomazicDepartment of Otorhinolaryngology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-6445-4800
Heinrich J HuberInstitute for Automation Engineering, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Rita SeeboeckDepartment Life Sciences, IMC University of Applied Sciences Krems, Krems, Austria.
Karoline FechterDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-6894-2438
Elisabeth SteinbauerDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Verena GruberDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Julia FeichtingerInstitute of Computational Biotechnology, Graz University of Technology, Graz, Austria.
Martin PichlerDepartment of Internal Medicine, Medical University of Graz, Graz, Austria.
Marc A WenigerInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.
Ralf KüppersInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.
Heinz SillDivision of Hematology, Medical University of Graz, Graz, Austria.
Rudolf SchichoDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Peter NeumeisterDivision of Hematology, Medical University of Graz, Graz, Austria.
Christine Beham-SchmidDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Alexander J A DeutschDivision of Hematology, Medical University of Graz, Graz, Austria.
Johannes HaybaeckDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria. johannes.haybaeck@med.ovgu.de.
Medical University of Graz · ATGerman Cancer Research Center · DEGraz University of Technology · ATIMC University of Applied Sciences Krems · ATOtto-von-Guericke-Universität Magdeburg · DEUniversity of Duisburg-Essen · DE

Funding

Austrian Science Fund FWF KLI 521Austrian Science Fund FWF P 25633Austrian Science Fund FWF P 30144Austrian Science Fund FWF T 923
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptomeB-LymphocytesFemaleHumansLymphoma, Large B-Cell, DiffuseMaleMultigene FamilyPrognosisTranscription FactorsELF2 protein, humanTranscription Factors

Identifiers

PMID30190479
PMCPMC6127263
OpenAlexW2888562112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.